Literature DB >> 22624716

ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in mice.

Hugh S Gannon1, Bruce A Woda2, Stephen N Jones3.   

Abstract

DNA damage induced by ionizing radiation activates the ATM kinase, which subsequently stabilizes and activates the p53 tumor suppressor protein. Although phosphorylation of p53 by ATM was found previously to modulate p53 levels and transcriptional activities in vivo, it does not appear to be a major regulator of p53 stability. We have utilized mice bearing altered Mdm2 alleles to demonstrate that ATM phosphorylation of Mdm2 serine 394 is required for robust p53 stabilization and activation after DNA damage. In addition, we demonstrate that dephosphorylation of Mdm2 Ser394 regulates attenuation of the p53-mediated response to DNA damage. Therefore, the phosphorylation status of Mdm2 Ser394 governs p53 protein levels and functions in cells undergoing DNA damage.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22624716      PMCID: PMC3360886          DOI: 10.1016/j.ccr.2012.04.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  46 in total

1.  Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.

Authors:  Melissa T Jack; Richard A Woo; Atsushi Hirao; Alison Cheung; Tak W Mak; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

Review 2.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage.

Authors:  Madhavsai Gajjar; Marco M Candeias; Laurence Malbert-Colas; Anne Mazars; Jun Fujita; Vanesa Olivares-Illana; Robin Fåhraeus
Journal:  Cancer Cell       Date:  2012-01-17       Impact factor: 31.743

4.  Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM.

Authors:  Ian Hickson; Yan Zhao; Caroline J Richardson; Sharon J Green; Niall M B Martin; Alisdair I Orr; Philip M Reaper; Stephen P Jackson; Nicola J Curtin; Graeme C M Smith
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

5.  Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.

Authors:  S N Jones; A R Hancock; H Vogel; L A Donehower; A Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

6.  Mutation of mouse p53 Ser23 and the response to DNA damage.

Authors:  Zhiqun Wu; John Earle; Shin'ichi Saito; Carl W Anderson; Ettore Appella; Yang Xu
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

Review 7.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

Review 8.  MDM2 is a central node in the p53 pathway: 12 years and counting.

Authors:  Gareth L Bond; Wenwei Hu; Arnold J Levine
Journal:  Curr Cancer Drug Targets       Date:  2005-02       Impact factor: 3.428

9.  ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

Authors:  R Maya; M Balass; S T Kim; D Shkedy; J F Leal; O Shifman; M Moas; T Buschmann; Z Ronai; Y Shiloh; M B Kastan; E Katzir; M Oren
Journal:  Genes Dev       Date:  2001-05-01       Impact factor: 11.361

10.  PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.

Authors:  Xiongbin Lu; Bonnie Nannenga; Lawrence A Donehower
Journal:  Genes Dev       Date:  2005-05-03       Impact factor: 11.361

View more
  44 in total

1.  A single synonymous mutation determines the phosphorylation and stability of the nascent protein.

Authors:  Konstantinos Karakostis; Sivakumar Vadivel Gnanasundram; Ignacio López; Aikaterini Thermou; Lixiao Wang; Karin Nylander; Vanesa Olivares-Illana; Robin Fåhraeus
Journal:  J Mol Cell Biol       Date:  2019-03-01       Impact factor: 6.216

2.  It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53.

Authors:  Ian M Love; Steven R Grossman
Journal:  Genes Cancer       Date:  2012-03

Review 3.  Genome Stability Requires p53.

Authors:  Christine M Eischen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

Review 4.  Harnessing and Optimizing the Interplay between Immunotherapy and Radiotherapy to Improve Survival Outcomes.

Authors:  Kalpana Mujoo; Clayton R Hunt; Raj K Pandita; Mauro Ferrari; Sunil Krishnan; John P Cooke; Stephen Hahn; Tej K Pandita
Journal:  Mol Cancer Res       Date:  2018-03-28       Impact factor: 5.852

5.  Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.

Authors:  Michael I Carr; Stephen N Jones
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

6.  Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis.

Authors:  Michael I Carr; Justine E Roderick; Hugh S Gannon; Michelle A Kelliher; Stephen N Jones
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

Review 7.  Drugging the p53 pathway: understanding the route to clinical efficacy.

Authors:  Kian Hoe Khoo; Khoo Kian Hoe; Chandra S Verma; David P Lane
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

8.  Mdm2 in evolution.

Authors:  David P Lane; Chandra Verma
Journal:  Genes Cancer       Date:  2012-03

9.  Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis.

Authors:  Hugh S Gannon; Stephen N Jones
Journal:  Genes Cancer       Date:  2012-03

10.  MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53.

Authors:  Magdalena Wienken; Antje Dickmanns; Alice Nemajerova; Daniela Kramer; Zeynab Najafova; Miriam Weiss; Oleksandra Karpiuk; Moustapha Kassem; Yanping Zhang; Guillermina Lozano; Steven A Johnsen; Ute M Moll; Xin Zhang; Matthias Dobbelstein
Journal:  Mol Cell       Date:  2015-12-31       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.